ENTEROBIOTIX

enterobiotix-logo

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.

#People #Financial #Website #More

ENTEROBIOTIX

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Life Science

Founded:
2017-01-01

Address:
Edinburgh, Edinburgh, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.enterobiotix.com

Total Employee:
1+

Status:
Active

Total Funding:
18 M GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail



Current Advisors List

mark-bamforth_image

Mark Bamforth Board Member @ EnteroBiotix
Board_member
2019-12-01

Current Employees Featured

not_available_image

Andrew Coleman
Andrew Coleman Director @ EnteroBiotix
Director
2017-01-01

james-mcilroy_image

James McIlroy
James McIlroy CEO @ EnteroBiotix
CEO
2017-03-01

not_available_image

Colin Bennett
Colin Bennett Non Executive Chairman @ EnteroBiotix
Non Executive Chairman
2017-03-01

Founder


james-mcilroy_image

James McIlroy

Investors List

kineticos-ventures_image

Kineticos Ventures

Kineticos Ventures investment in Series A - EnteroBiotix

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Series A - EnteroBiotix

thairm-bio_image

Thairm Bio

Thairm Bio investment in Series A - EnteroBiotix

sis-ventures_image

SIS Ventures

SIS Ventures investment in Series A - EnteroBiotix

bank-workers-charity_image

Bank Workers Charity

Bank Workers Charity investment in Seed Round - EnteroBiotix

university-of-aberdeen_image

University of Aberdeen

University of Aberdeen investment in Seed Round - EnteroBiotix

scottish-investment-bank_image

Scottish Investment Bank

Scottish Investment Bank investment in Seed Round - EnteroBiotix

equity-gap_image

Equity Gap

Equity Gap investment in Seed Round - EnteroBiotix

scottish-investment-bank_image

Scottish Investment Bank

Scottish Investment Bank investment in Seed Round - EnteroBiotix

equity-gap_image

Equity Gap

Equity Gap investment in Seed Round - EnteroBiotix

Official Site Inspections

http://www.enterobiotix.com Semrush global rank: 1.54 M Semrush visits lastest month: 16.97 K

  • Host name: 198.49.23.144
  • IP address: 198.49.23.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "EnteroBiotix"

EnteroBiotix - Crunchbase Company Profile & Funding

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing …See details»

EnteroBiotix - LinkedIn

EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to ...See details»

Life at EnteroBiotix — EnteroBiotix

If you think you would be a good fit for our team then please email your CV and covering letter to careers@enterobiotix.com. Find out more about our donor programme. Visit Number2.org . …See details»

EnteroBiotix 2025 Company Profile: Valuation, Funding ... - PitchBook

EnteroBiotix General Information Description. Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. The company focuses on creating …See details»

Enterobiotix - 2025 Company Profile - Tracxn

Apr 7, 2025 Enterobiotix is a series B company based in Edinburgh (United Kingdom), founded in 2017. It operates as a Developer of microbiome-based therapeutics for multiple disease …See details»

EnteroBiotix - VentureRadar

EnteroBiotix was established to unlock the full therapeutic potential of Faecal Microbiota Transplantation (FMT) through three core product portfolios targeted at different diseases. Our …See details»

A leading gut therapeutics company — …

Led by an entrepreneurial and experienced management team, supported by a distinguished Board, we're on a mission to transform the lives of patients through best-in-class gut …See details»

EnteroBiotix Company Profile - Craft

EnteroBiotix is a biopharmaceutical company that develops a microbiome therapeutics platform. It utilizes gut microbiome to develop novel medicinal products that restore health and prevent …See details»

EnteroBiotix - Funding, Financials, Valuation & Investors

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. New. Resources. Advanced Search. ... How much funding has this …See details»

EnteroBiotix | Startup Profile and Investments - Bounce Watch

EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections …See details»

Microbes Reveal Clues About Extraterrestrial Life

1 day ago Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, …See details»

About EnteroBiotix - PharmiWeb.jobs

Apr 5, 2024 EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics for patients with serious unmet medical needs. The …See details»

EnteroBiotix Announces Positive Topline Phase 2a Results with EBX …

Glasgow, Scotland – 18 March 2025. EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today …See details»

EnteroBiotix lands $34m to take microbiome therapeutics into …

Apr 5, 2024 Microbiome therapeutics company EnteroBiotix has successfully concluded a $34m funding round to support the advancement of clinical programs targeting multiple chronic …See details»

Pioneering gut health biopharma set to expand

Dr James McIlroy, EnteroBiotix CEO and Simon Comer, Scottish National Investment Bank. Financing round totalling £27m enables business to expand and progress clinical trials …See details»

EnteroBiotix - Overview, News & Similar companies - ZoomInfo

Jul 17, 2023 EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy GLASGOW, United Kingdom, March 28, 2023 (GLOBE …See details»

EnteroBiotix - Contacts, Employees, Board Members, Advisors

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»

EnteroBiotix Expands Headcount and Premises to Advance …

Glasgow, Scotland – 27 October 2021 – EnteroBiotix, a biopharmaceutical company developing novel highly-diverse microbial therapeutics that enhance the gut microbiome, today …See details»

EnteroBiotix Announces MHRA License Approval and …

Sep 10, 2018 EnteroBiotix, a leading clinical stage microbiome therapeutics company, has been granted a manufacturers ‘specials’ license from the Medicines and Healthcare Products …See details»

Frontrunner in Microbiome Therapeutics - PharmTech

Mar 3, 2023 11. EnteroBiotix. EnteroBiotix Receives MHRA MIA (IMP) Licensure of State‑of-the-Art GMP Manufacturing Facility for Producing Microbiome Therapeutics. Press Release, 11 …See details»

linkstock.net © 2022. All rights reserved